February 16, 2026

You've tried physical therapy, medications, injections—maybe even surgery. The pain is still there.

You're not alone. Between 20% and 40% of patients who undergo back surgery develop chronic pain afterward, a condition doctors call failed back surgery syndrome. For these patients, and for millions of others living with conditions like complex regional pain syndrome, the search for relief can feel endless.

Two advanced neurostimulation technologies offer a different approach: dorsal root ganglion stimulation vs spinal cord stimulation. Both use implanted devices to interrupt pain signals before they reach your brain. Both have helped patients reduce or eliminate their reliance on pain medications. But they work in fundamentally different ways—and understanding that difference is the first step toward finding the solution that actually works for your specific pain.

This guide breaks down how each technology works, what conditions respond best to each, and how to determine which option fits your situation.

Understanding Neuromodulation for Chronic Pain

What Is Neuromodulation?

Neuromodulation uses electrical impulses to change how your nervous system processes pain signals. It doesn't eliminate the source of your pain—a damaged nerve, a herniated disc, scar tissue from surgery. Instead, it changes how your brain perceives those signals.

The concept is similar to noise-canceling headphones. The pain signal still exists, but the device creates interference that prevents it from registering normally. An implanted pulse generator (about the size of a pacemaker) delivers controlled electrical stimulation through thin wires called leads. You control the device with an external remote, adjusting intensity or turning it on and off as needed.

When Is Neuromodulation Recommended?

Doctors typically recommend neuromodulation when conservative treatments have failed to provide adequate relief. This means physical therapy, medications, and injections haven't worked—or have stopped working. The pain has persisted for six months or longer, and it significantly affects your daily life, sleep, or ability to work.

You may also be a candidate if you're not eligible for additional surgery, or if previous surgery didn't resolve your pain. For patients exploring chronic pain treatment options, neuromodulation represents an alternative when other approaches have been exhausted.

How Spinal Cord Stimulation Works

The Traditional Approach

Spinal cord stimulation has been FDA-approved since the 1980s, giving it decades of clinical data and refinement. The procedure involves placing thin leads in the epidural space along the spinal cord. These leads deliver electrical pulses to the dorsal columns—the sensory pathways running along the back of your spinal cord.

The stimulation creates broad coverage over larger pain areas, effectively blocking pain signals from traveling up to your brain. Think of it as placing a gate across a highway—signals that would normally pass through freely get stopped or redirected.

What It Treats

Spinal cord stimulation works well for widespread pain patterns. Common conditions include failed back surgery syndrome with diffuse pain across the back and legs, complex regional pain syndrome affecting multiple areas, and diabetic neuropathy that spans large regions of the body. It can also address chronic pain in the arms, trunk, or both legs simultaneously.

The Paresthesia Trade-Off

Most traditional spinal cord stimulators create a tingling or buzzing sensation called paresthesia. This sensation replaces the pain—you feel something, but not the sharp or burning pain you had before. Some patients find this acceptable. Others find the constant tingling distracting, especially during sleep or when trying to concentrate.

Newer high-frequency spinal cord stimulation systems reduce paresthesia, but don't eliminate it entirely. About 61% of patients still experience some degree of tingling with traditional devices.

How Dorsal Root Ganglion Stimulation Is Different

Targeting the Sensory Gate

Dorsal root ganglion stimulation takes a different approach. Instead of stimulating the spinal cord itself, it targets the dorsal root ganglion—a cluster of nerve cell bodies located just outside the spinal cord where spinal nerves branch off.

Every sensory signal from your body must pass through a DRG before reaching the spinal cord. Pain from your foot, knee, or hip all funnel through specific ganglia on their way to your brain. By stimulating at this junction, DRG therapy intercepts pain closer to its source rather than downstream at the spinal cord. The FDA approved this technology in 2016 specifically for complex regional pain syndrome in the lower extremities.

Precision Targeting for Focal Pain

Each dorsal root ganglion maps to a specific body region. This anatomical organization allows surgeons to target foot pain, knee pain, groin pain, or hip pain with precision that spinal cord stimulation can't match.

Because DRG stimulation covers a smaller, more defined area, it requires far less energy—about 10% of what traditional spinal cord stimulation uses. This efficiency translates to battery life. A DRG stimulator battery can last 10 years or longer, compared to 2-5 years for most spinal cord stimulator batteries.

The Paresthesia-Free Advantage

Here's where many patients notice the biggest difference: 94.5% of DRG patients achieve pain relief without any tingling sensation. The pain doesn't get replaced by buzzing or vibration. It simply diminishes. Patients describe this as more natural—you're not constantly aware that a device is working inside your body. For those who tried spinal cord stimulation but couldn't tolerate the paresthesia, this distinction matters.

Head-to-Head Comparison: DRG vs SCS

Pain Relief Effectiveness

Both technologies provide meaningful relief, but the numbers favor DRG for certain conditions. At one year, 67.3% of DRG patients achieve greater than 80% pain relief, compared to 54% for spinal cord stimulation patients. That gap narrows for widespread pain patterns where SCS coverage is more appropriate. The question isn't which device is "better"—it's which one matches your specific pain.

Coverage Area

Spinal cord stimulation provides broader coverage, making it well-suited for pain that spans your entire back, both legs, or multiple body regions. DRG stimulation works like a spotlight rather than a floodlight—excellent for isolated pain in a single foot, one knee, the groin, or a specific joint. If your pain is diffuse, SCS may serve you better. If it's localized to one area, DRG often delivers superior results.

Side Effects and Sensation

The paresthesia difference is significant in daily life. About 61% of spinal cord stimulation patients experience tingling or buzzing, which can interfere with sleep and concentration. DRG stimulation leaves 94.5% of patients paresthesia-free. For patients who find replacement sensations distracting or uncomfortable, this often becomes the deciding factor.

Battery Life and Maintenance

DRG systems use 90% less energy than traditional spinal cord stimulators. Batteries in DRG devices can last 10 years or more before requiring surgical replacement. Spinal cord stimulator batteries typically need replacement every 2-5 years, meaning additional procedures over your lifetime.

Lead Migration Risk

Spinal cord stimulators sit in the epidural space, where body movement can cause them to shift position over time. When leads migrate, stimulation coverage changes, and the device becomes less effective. DRG leads sit in a smaller, more anatomically stable location, resulting in significantly lower migration rates.

Which Conditions Respond Best to Each Treatment?

Best Candidates for Spinal Cord Stimulation

Spinal cord stimulation works best when pain covers a large territory. If you have widespread back and leg pain affecting both sides of your body, SCS can provide the broad coverage you need. Failed back surgery syndrome with diffuse pain—not isolated to one spot—responds well to this approach.

Patients with diabetic neuropathy affecting large regions, chronic arm pain, chest wall pain, or pain in multiple limbs often find SCS more practical than trying to target several DRG sites. When pursuing interventional pain management for complex, multi-area pain, spinal cord stimulation remains the standard approach.

Best Candidates for DRG Stimulation

DRG stimulation excels when pain is concentrated in a specific location. Complex regional pain syndrome in the foot, ankle, knee, or hip is the condition DRG was designed to treat—and where it consistently outperforms spinal cord stimulation.

Other strong candidates include chronic pain following knee replacement or hip replacement surgery, isolated foot pain from diabetic neuropathy, groin or pelvic pain, and phantom limb pain after amputation. Patients with failed back surgery syndrome who have focal leg or foot pain—rather than diffuse pain throughout the back and legs—often achieve better results with DRG.

When DRG May Be Preferred

Three scenarios point toward DRG as the better choice. First, if you tried spinal cord stimulation but couldn't tolerate the paresthesia. Second, if your pain is in a hard-to-reach area for SCS, such as the foot, knee, or groin. Third, if you want the longest possible battery life and fewest maintenance procedures over time.

The Trial Process: Testing Before Committing

Why a Trial Period Matters

Neither spinal cord stimulation nor DRG stimulation requires you to commit to permanent surgery without knowing if it works. Both technologies require a 5-7 day trial period before any permanent implant.

During the trial, your surgeon places temporary leads using a minimally invasive outpatient procedure. You go home the same day wearing an external pulse generator on your belt. For the next week, you live your normal life—working, sleeping, moving through your daily routine—while the device delivers stimulation.

This real-world testing period removes the guesswork. You experience actual pain relief (or lack of it) before making a surgical decision. To qualify for a permanent implant, you must achieve at least 50% reduction in pain during the trial. If the trial doesn't provide adequate relief, the leads are simply removed. No permanent device gets implanted.

What to Expect

The trial procedure uses local anesthesia, and most patients describe minimal discomfort. During the trial week, you'll track your pain levels, how much pain medication you use, and whether your activity level improves. You'll note how well you sleep and whether you can do things the pain previously prevented.

Your pain management team reviews this data with you at the end of the trial. If the results meet the threshold—and you're satisfied with the experience—you'll schedule the permanent implant procedure. If the results fall short, you

Success Rates and What to Expect

Clinical Outcomes

The numbers support both technologies for the right candidates. For DRG stimulation treating complex regional pain syndrome, 70% of patients achieve greater than 80% pain relief at three months. At one year, 67% maintain that level of improvement—a strong indicator of lasting benefit rather than temporary effect.

Spinal cord stimulation for failed back surgery syndrome shows 50-70% of patients achieving significant pain reduction, depending on the study and patient selection criteria. Both approaches help most patients reduce or eliminate opioid medications, which carries its own quality-of-life benefits beyond pain scores.

Patients consistently report improved sleep, better mood, and the ability to return to activities they had abandoned. Some go back to work. Others resume hobbies, travel, or simply get through a day without pain dominating every decision.

Not a Cure, But Life-Changing Relief

Neither technology fixes the underlying problem. If you have nerve damage from diabetes, the nerve damage remains. If you have scar tissue from a failed surgery, the scar tissue stays. What changes is how your brain registers the pain signals from those damaged areas.

This distinction matters for setting realistic expectations. Neuromodulation doesn't make you "pain-free" in most cases—it makes pain manageable. Patients describe it as getting their life back, not as a miracle cure. The pain drops from a constant 8 or 9 to a 2 or 3. That shift changes everything about daily life, even if some awareness of discomfort remains.

How to Decide Which Is Right for You

The Evaluation Process

Choosing between DRG and spinal cord stimulation isn't something you do alone. The decision comes from a thorough evaluation with a neurosurgeon or pain management specialist who performs both procedures.

Your evaluation will include a review of imaging—MRI and CT scans that show the structural source of your pain. You'll discuss your pain pattern in detail: Is it widespread or focal? Constant or positional? Does it affect one leg or both? Your doctor will review what treatments you've already tried and why they failed.

Most programs also include a psychological evaluation. Chronic pain affects mental health, and mental health affects pain perception. Addressing both gives you the best chance of success with any neuromodulation approach. When working with neurosurgery specialists, expect this comprehensive assessment before any procedure is scheduled.

Questions to Ask Your Surgeon

Come prepared with specific questions. Based on my pain pattern, am I a candidate for DRG, spinal cord stimulation, or both? What are your personal success rates with each device for my specific condition? How many of these procedures do you perform each year?

Ask about the trial period: What exactly happens during those five to seven days? What counts as success? And what happens if the trial doesn't work—what options remain?

The answers will tell you whether you're in the right hands. A surgeon who performs both procedures regularly and can discuss outcomes honestly—including failures—is better positioned to recommend what fits your situation than one who only offers a single technology.

Conclusion

Both dorsal root ganglion stimulation and spinal cord stimulation offer real hope when medications, injections, and surgery have failed to control your chronic pain. The right choice depends on your specific situation, not on which technology is "newer" or "better" in the abstract.

DRG stimulation delivers precision targeting, paresthesia-free relief, and longer battery life—making it the stronger option for focal pain in the lower limbs, particularly complex regional pain syndrome, post-surgical joint pain, and isolated foot or knee pain.

Spinal cord stimulation provides broader coverage with decades of clinical evidence behind it—making it the better fit for widespread back and leg pain, diffuse failed back surgery syndrome, and pain affecting multiple body regions simultaneously.

The trial period exists specifically so you don't have to guess. You experience real relief—or you don't—before committing to a permanent implant. That built-in testing phase removes much of the risk from the decision.

Chronic pain doesn't have to be permanent. If you've exhausted other options and want to explore whether neuromodulation could work for you, the next step is a consultation with a specialist who performs both procedures. You can find a neurosurgeon near you who can evaluate your pain pattern, review your history, and help you determine whether DRG or spinal cord stimulation is the right path forward.

Frequently Asked Questions

Can DRG stimulation help diabetic neuropathy?

Yes. DRG stimulation is particularly effective for diabetic foot pain when the symptoms are concentrated in a specific area rather than spread throughout both legs. By targeting the L5 dorsal root ganglion, surgeons can relieve pain in the foot with precision that spinal cord stimulation often cannot match. For patients with focal diabetic neuropathy—burning or stabbing pain isolated to the feet—DRG is emerging as a preferred treatment option.

Will I feel tingling with a dorsal root ganglion stimulator?

Most patients do not. In clinical studies, 94.5% of DRG patients experienced pain relief without paresthesia. The pain diminishes without being replaced by buzzing, tingling, or vibration. This differs from traditional spinal cord stimulation, where most patients feel some degree of tingling sensation as part of the therapy.

What if spinal cord stimulation didn't work for me—can I try DRG?

Absolutely. Many patients who couldn't tolerate spinal cord stimulation paresthesia or didn't achieve adequate pain coverage have found success with DRG's targeted approach. If your SCS failed because the coverage didn't reach your foot or knee, or because the tingling was too distracting, DRG addresses both of those limitations. A trial period will determine whether DRG works for your specific pain before any permanent device is implanted.

How long does the battery last in a DRG stimulator?

DRG systems use approximately 10% of the energy required by traditional spinal cord stimulators. This efficiency means batteries can last 10 years or longer before surgical replacement is needed—compared to 2-5 years for most SCS batteries. Over a lifetime of treatment, this difference can mean several fewer replacement surgeries.

Choosing between dorsal root ganglion and spinal cord stimulation comes down to where your pain lives and a surgeon who's done both. Chat with us to find a pain neurosurgeon near you.